Gilead Sciences is charging American patients with private insurance more than $3,000 for its COVID-19 treatment. ICU beds in COVID hot spots across the South and West are filling up and demand for COVID tests is quickly outpacing supply.
Hosted on Acast. See acast.com/privacy for more information.
